메뉴 건너뛰기




Volumn 74, Issue 3, 2003, Pages 203-214

Randomized concentration-controlled trials: Motivations, use, and limitations

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; 4 AMINOPYRIDINE; AMITRIPTYLINE; CYCLOSPORIN; ETANIDAZOLE; ETOPOSIDE; FLUNARIZINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; MIDAZOLAM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; RAPAMYCIN; SURAMIN; TACROLIMUS; THEOPHYLLINE; VALPROATE SEMISODIUM; VALPROIC ACID;

EID: 0042833216     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00169-3     Document Type: Note
Times cited : (30)

References (48)
  • 1
    • 0034971415 scopus 로고    scopus 로고
    • Concentration-controlled or effect-controlled trials: Useful alternatives to conventional dose-controlled trials?
    • Grahnen A, Karlsson MO. Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials? Clin Pharmacokinet 2001;40:317-25.
    • (2001) Clin Pharmacokinet , vol.40 , pp. 317-325
    • Grahnen, A.1    Karlsson, M.O.2
  • 2
    • 0038313971 scopus 로고
    • The randomized concentration-controlled clinical trial (CCT): An information-rich alternative to the randomized placebo controlled clinical trial (PCT)
    • Peck C. The randomized concentration-controlled clinical trial (CCT): an information-rich alternative to the randomized placebo controlled clinical trial (PCT) [abstract]. Clin Pharmacol Ther 1990;47:148.
    • (1990) Clin Pharmacol Ther , vol.47 , pp. 148
    • Peck, C.1
  • 3
    • 0026320316 scopus 로고
    • The randomized concentration-controlled trial: An evaluation of its sample-size efficiency
    • Sanathanan LP, Peck CC. The randomized concentration-controlled trial: an evaluation of its sample-size efficiency. Control Clin Trials 1991;12:780-94.
    • (1991) Control Clin Trials , vol.12 , pp. 780-794
    • Sanathanan, L.P.1    Peck, C.C.2
  • 4
    • 0032545976 scopus 로고    scopus 로고
    • Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia
    • Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998;338:499-505.
    • (1998) N Engl J Med , vol.338 , pp. 499-505
    • Evans, W.E.1    Relling, M.V.2    Rodman, J.H.3    Crom, W.R.4    Boyett, J.M.5    Pui, C.H.6
  • 6
    • 0028043964 scopus 로고
    • Comparative efficiencies of randomized concentration- and dose-controlled clinical trials
    • Endrenyi L, Zha J. Comparative efficiencies of randomized concentration- and dose-controlled clinical trials. Clin Pharmacol Ther 1994;56:331-8.
    • (1994) Clin Pharmacol Ther , vol.56 , pp. 331-338
    • Endrenyi, L.1    Zha, J.2
  • 8
    • 0042484413 scopus 로고
    • Bias and efficiency effects of correlation between pharmacokinetics and pharmacodynamics in post-hoc concentration-effect analyses of parallel dose-response trials
    • Peck C, Ludden T. Bias and efficiency effects of correlation between pharmacokinetics and pharmacodynamics in post-hoc concentration-effect analyses of parallel dose-response trials [abstract]. Clin Pharmacol Ther 1994;55:163.
    • (1994) Clin Pharmacol Ther , vol.55 , pp. 163
    • Peck, C.1    Ludden, T.2
  • 9
    • 0034119297 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic modeling in drug development
    • Sheiner LB, Steimer JL. Pharmacokinetic/pharmacodynamic modeling in drug development. Annu Rev Pharmacol Toxicol 2000;40:67-95.
    • (2000) Annu Rev Pharmacol Toxicol , vol.40 , pp. 67-95
    • Sheiner, L.B.1    Steimer, J.L.2
  • 10
    • 0025088923 scopus 로고
    • Factors related to treatment resistance in hypertension
    • Toner JM, Close CF, Ramsay LE. Factors related to treatment resistance in hypertension. Q J Med 1990;77:1195-204.
    • (1990) Q J Med , vol.77 , pp. 1195-1204
    • Toner, J.M.1    Close, C.F.2    Ramsay, L.E.3
  • 11
    • 0030904722 scopus 로고    scopus 로고
    • Mechanisms and management of renal dysfunction in heart failure
    • Anand IS, Chugh SS. Mechanisms and management of renal dysfunction in heart failure. Curr Opin Cardiol 1997;12:251-8.
    • (1997) Curr Opin Cardiol , vol.12 , pp. 251-258
    • Anand, I.S.1    Chugh, S.S.2
  • 12
    • 0022968221 scopus 로고
    • Effect of disease states on theophylline elimination
    • Jenne JW. Effect of disease states on theophylline elimination. J Allergy Clin Immunol 1986;78(4 Pt 2):727-35.
    • (1986) J Allergy Clin Immunol , vol.78 , Issue.4 PART 2 , pp. 727-735
    • Jenne, J.W.1
  • 13
    • 0027373162 scopus 로고
    • Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial
    • Holford N, Hashimoto Y, Sheiner LB. Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial. Clin Pharmacokinet 1993;25:506-15.
    • (1993) Clin Pharmacokinet , vol.25 , pp. 506-515
    • Holford, N.1    Hashimoto, Y.2    Sheiner, L.B.3
  • 15
    • 0042985226 scopus 로고
    • The study of antimalarials and antimalarial activity in the human malarias
    • Shannon JA. The study of antimalarials and antimalarial activity in the human malarias. Harvey Lect 1945-1946;41:43-89.
    • (1945) Harvey Lect , vol.41 , pp. 43-89
    • Shannon, J.A.1
  • 16
    • 0017654093 scopus 로고
    • Phenytoin in the treatment of diabetic symmetrical polyneuropathy
    • Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977;22:196-9.
    • (1977) Clin Pharmacol Ther , vol.22 , pp. 196-199
    • Saudek, C.D.1    Werns, S.2    Reidenberg, M.M.3
  • 17
    • 0020078179 scopus 로고
    • A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
    • A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-14.
    • (1982) JAMA , vol.247 , pp. 1707-1714
  • 18
    • 0018893088 scopus 로고
    • Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia
    • Baber NS, Evans DW, Howitt G, Thomas M, Wilson T, Lewis JA, et al. Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia. Br Heart J 1980;44:96-100.
    • (1980) Br Heart J , vol.44 , pp. 96-100
    • Baber, N.S.1    Evans, D.W.2    Howitt, G.3    Thomas, M.4    Wilson, T.5    Lewis, J.A.6
  • 19
    • 0020038813 scopus 로고
    • Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: The optimal use of intravenously administered aminophylline
    • Vozeh S, Kewitz G, Perruchoud A, Tschan M, Kopp C, Heitz M, et al. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. Am Rev Respir Dis 1982;125:181-4.
    • (1982) Am Rev Respir Dis , vol.125 , pp. 181-184
    • Vozeh, S.1    Kewitz, G.2    Perruchoud, A.3    Tschan, M.4    Kopp, C.5    Heitz, M.6
  • 20
    • 0029983739 scopus 로고    scopus 로고
    • The effect of midazolam at two plasma concentrations of hemodynamics and sufentanil requirement in coronary artery surgery
    • van der Maaten JM, Epema AH, Huet RC, Hennis PJ. The effect of midazolam at two plasma concentrations of hemodynamics and sufentanil requirement in coronary artery surgery. J Cardiothorac Vasc Anesth 1996;10:356-63.
    • (1996) J Cardiothorac Vasc Anesth , vol.10 , pp. 356-363
    • Van Der Maaten, J.M.1    Epema, A.H.2    Huet, R.C.3    Hennis, P.J.4
  • 22
    • 0039878338 scopus 로고
    • Analysis of clinical pharmacokinetics data for individualizing drug dosage regimens
    • Evans W, Schentag J, Jusko W, editors. San Francisco: Applied Therapeutics
    • Peck C, D'Argenio DZ, Rodman J. Analysis of clinical pharmacokinetics data for individualizing drug dosage regimens. In: Evans W, Schentag J, Jusko W, editors. Applied pharmacokinetics. San Francisco: Applied Therapeutics; 1992. p. 3-1-3-31.
    • (1992) Applied Pharmacokinetics , pp. 31-331
    • Peck, C.1    D'Argenio, D.Z.2    Rodman, J.3
  • 25
    • 0027478845 scopus 로고
    • Concentration-controlled versus concentration-defined clinical trials
    • Levy G. Concentration-controlled versus concentration-defined clinical trials. Clin Pharmacol Ther 1993;53:385-8.
    • (1993) Clin Pharmacol Ther , vol.53 , pp. 385-388
    • Levy, G.1
  • 26
    • 0029810665 scopus 로고    scopus 로고
    • Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: Multiple sclerosis and primary biliary cirrhosis
    • McMichael J, Lieberman R, McCauley J, Irish W, Marino I, Doyle H. Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. Ther Drug Monit 1996;18:435-7.
    • (1996) Ther Drug Monit , vol.18 , pp. 435-437
    • McMichael, J.1    Lieberman, R.2    McCauley, J.3    Irish, W.4    Marino, I.5    Doyle, H.6
  • 28
    • 0033609476 scopus 로고    scopus 로고
    • A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
    • Van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999;68:261-6.
    • (1999) Transplantation , vol.68 , pp. 261-266
    • Van Gelder, T.1    Hilbrands, L.B.2    Vanrenterghem, Y.3    Weimar, W.4    De Fijter, J.W.5    Squifflet, J.P.6
  • 29
    • 18244427344 scopus 로고    scopus 로고
    • Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients
    • Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000;69:1252-60.
    • (2000) Transplantation , vol.69 , pp. 1252-1260
    • Kreis, H.1    Cisterne, J.M.2    Land, W.3    Wramner, L.4    Squifflet, J.P.5    Abramowicz, D.6
  • 30
    • 0345161813 scopus 로고    scopus 로고
    • Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine
    • Sirolimus European Renal Transplant Study Group
    • Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999;67:1036-42.
    • (1999) Transplantation , vol.67 , pp. 1036-1042
    • Groth, C.G.1    Backman, L.2    Morales, J.M.3    Calne, R.4    Kreis, H.5    Lang, P.6
  • 31
    • 0028245456 scopus 로고
    • The effects of 4-aminopyridine in multiple sclerosis patients: Results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial
    • Bever CT Jr, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, et al. The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology 1994;44:1054-9.
    • (1994) Neurology , vol.44 , pp. 1054-1059
    • Bever C.T., Jr.1    Young, D.2    Anderson, P.A.3    Krumholz, A.4    Conway, K.5    Leslie, J.6
  • 32
    • 0024330649 scopus 로고
    • Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder
    • Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-93.
    • (1989) N Engl J Med , vol.321 , pp. 1489-1493
    • Gelenberg, A.J.1    Kane, J.M.2    Keller, M.B.3    Lavori, P.4    Rosenbaum, J.F.5    Cole, K.6
  • 34
    • 0028007333 scopus 로고
    • Relationship between plasma concentrations of 3′-deoxy-3′ -fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials
    • Flexner C, van der Horst C, Jacobson MA, Powderly W, Duncanson F, Ganes D, et al. Relationship between plasma concentrations of 3′-deoxy-3′ -fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. J Infect Dis 1994;170:1394-403.
    • (1994) J Infect Dis , vol.170 , pp. 1394-1403
    • Flexner, C.1    Van Der Horst, C.2    Jacobson, M.A.3    Powderly, W.4    Duncanson, F.5    Ganes, D.6
  • 35
    • 0030666643 scopus 로고    scopus 로고
    • Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial
    • Riese NE, Buswell L, Noll L, Pajak TF, Stetz J, Lee DJ, et al. Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial. Int J Radiat Oncol Biol Phys 1997;39:855-8.
    • (1997) Int J Radiat Oncol Biol Phys , vol.39 , pp. 855-858
    • Riese, N.E.1    Buswell, L.2    Noll, L.3    Pajak, T.F.4    Stetz, J.5    Lee, D.J.6
  • 36
    • 0029827498 scopus 로고    scopus 로고
    • A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: Toxicity and response
    • Bowden CJ, Figg WD, Dawson NA, Sartor O, Bitton RJ, Weinberger MS, et al. A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response. Cancer Chemother Pharmacol 1996;39:1-8.
    • (1996) Cancer Chemother Pharmacol , vol.39 , pp. 1-8
    • Bowden, C.J.1    Figg, W.D.2    Dawson, N.A.3    Sartor, O.4    Bitton, R.J.5    Weinberger, M.S.6
  • 37
    • 0029127207 scopus 로고
    • Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer
    • Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jodrell DI, Zuhowski EG, et al. Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. J Clin Oncol 1995;13:2174-86.
    • (1995) J Clin Oncol , vol.13 , pp. 2174-2186
    • Eisenberger, M.A.1    Sinibaldi, V.J.2    Reyno, L.M.3    Sridhara, R.4    Jodrell, D.I.5    Zuhowski, E.G.6
  • 38
    • 0026794763 scopus 로고
    • A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
    • The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group
    • Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992;327:765-71.
    • (1992) N Engl J Med , vol.327 , pp. 765-771
    • Mattson, R.H.1    Cramer, J.A.2    Collins, J.F.3
  • 39
    • 0024991892 scopus 로고
    • A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
    • Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
    • (1990) N Engl J Med , vol.323 , pp. 497-502
    • Temkin, N.R.1    Dikmen, S.S.2    Wilensky, A.J.3    Keihm, J.4    Chabal, S.5    Winn, H.R.6
  • 42
    • 0031743076 scopus 로고    scopus 로고
    • A randomised, concentration-controlled, comparison of standard (5-day) vs prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
    • Joel S, O'Byrne K, Penson R, Papamichael D, Higgins A, Robertshaw H, et al. A randomised, concentration-controlled, comparison of standard (5-day) vs prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer. Ann Oncol 1998;9:1205-11.
    • (1998) Ann Oncol , vol.9 , pp. 1205-1211
    • Joel, S.1    O'Byrne, K.2    Penson, R.3    Papamichael, D.4    Higgins, A.5    Robertshaw, H.6
  • 43
    • 0034127343 scopus 로고    scopus 로고
    • Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia
    • Wassef AA, Dott SG, Harris A, Brown A, O'Boyle M, Meyer WJ III, et al. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 2000;20:357-61.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 357-361
    • Wassef, A.A.1    Dott, S.G.2    Harris, A.3    Brown, A.4    O'Boyle, M.5    Meyer W.J. III6
  • 44
    • 0030892848 scopus 로고    scopus 로고
    • A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder
    • Solomon DA, Ryan CE, Keitner GI, Miller IW, Shea MT, Kazim A, et al. A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder. J Clin Psychiatry 1997;58:95-9.
    • (1997) J Clin Psychiatry , vol.58 , pp. 95-99
    • Solomon, D.A.1    Ryan, C.E.2    Keitner, G.I.3    Miller, I.W.4    Shea, M.T.5    Kazim, A.6
  • 45
    • 0029805879 scopus 로고    scopus 로고
    • An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: A report of the United States Multicenter FK506 Kidney Transplant Group
    • Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation 1996;62:900-5.
    • (1996) Transplantation , vol.62 , pp. 900-905
    • Laskow, D.A.1    Vincenti, F.2    Neylan, J.F.3    Mendez, R.4    Matas, A.J.5
  • 46
    • 0023902794 scopus 로고
    • Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges
    • Berl
    • Burch JE, Ahmed O, Hullin RP, Mindham RH. Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges. Psychopharmacology (Berl) 1988;94:197-205.
    • (1988) Psychopharmacology , vol.94 , pp. 197-205
    • Burch, J.E.1    Ahmed, O.2    Hullin, R.P.3    Mindham, R.H.4
  • 47
    • 0023932517 scopus 로고
    • If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study
    • Woo E, Chan YM, Yu YL, Chan YW, Huang CY. If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia 1988;29:129-39.
    • (1988) Epilepsia , vol.29 , pp. 129-139
    • Woo, E.1    Chan, Y.M.2    Yu, Y.L.3    Chan, Y.W.4    Huang, C.Y.5
  • 48
    • 0018092645 scopus 로고
    • Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant rate intravenous infusion
    • Chiou WL, Gadalla MAE, Peng GW. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant rate intravenous infusion. J Pharmacokinet Biopharm 1978;6:135-51.
    • (1978) J Pharmacokinet Biopharm , vol.6 , pp. 135-151
    • Chiou, W.L.1    Gadalla, M.A.E.2    Peng, G.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.